Advertisement
Advertisement
U.S. markets close in 1 hour 44 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Oncorus, Inc. (ONCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.6000+0.2600 (+7.78%)
As of 02:13PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.3400
Open3.2800
Bid3.5000 x 800
Ask3.5300 x 900
Day's Range3.1500 - 3.6500
52 Week Range3.1500 - 26.7660
Volume49,911
Avg. Volume232,633
Market Cap92.912M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ONCR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Oncorus, Inc.
    Daily – Vickers Top Buyers & Sellers for 12/09/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • GlobeNewswire

    Oncorus to Present at the H.C. Wainwright BioConnect Virtual Conference

    CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in a fireside chat at the H.C. Wainwright BioConnect Conference. The fireside chat will be available for on-demand viewing beginning Monday, January 10, 2022 at 7:00am ET under the Investors & Media

  • GlobeNewswire

    Oncorus to Present at Upcoming Investor Conferences

    CAMBRIDGE, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in two upcoming virtual investor conferences: 33rd Annual Piper Sandler Virtual Healthcare Conference: A corporate presentation will be available on-demand starting Monday, November 22nd at 10:00 a.m

  • GlobeNewswire

    Oncorus to Present at the Jefferies London Healthcare Conference

    CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will present at the Jefferies London Healthcare Conference. The presentation will be available for on-demand viewing beginning Thursday, November 18, 2021 at 3:00 a.m. ET under the Investors & Media section of Oncoru

Advertisement
Advertisement